Heart Failure Devices Global Market is estimated to be worth $38,879.9 million by 2029

IQ4I Research & Consultancy published a new report on “Heart Failure Devices Global Market – Forecast To 2029”

The Heart Failure Devices global market report covers five segments namely product, end-user, surgery, and geography. These segments are further segmented as follows:
1) Heart Failure Devices global market, Based on Product:
 Cardiac rhythm products
o Cardiac rhythm based on Product Type
 Implantable Cardioverter Defibrillators (ICD)
o Single chamber ICD
o Dual chamber ICD
 Pacemakers
o Single chamber pacemaker
o Dual chamber pacemaker
 Cardiac Resynchronization Therapy (CRT)
o Cardiac Resynchronization Therapy Defibrillator (CRT-D)
o Cardiac resynchronization Therapy Pacemaker (CRT-P)
 Cardiac Assist Devices
o Cardiac assist device based on Product Type
 Ventricular assist device (VAD)
o Left Ventricular Assist Device (LVAD)
o Right Ventricular Assist Device (RVAD)
o Bi-Ventricular Assist Device (Bi-VAD)
 Intra-Aortic Balloon Pump (IABP)
 Total Artificial Heart (TAH)
o
 Structural Heart Devices
 Repair devices
o Annuloplasty
o Valvuloplasty
o Occluders
o Transcatheter Mitral Valve Repair (TMVr)
o Others (Chrodal replacement, TTVR, Ventricular restoration system, & Shunt)
 Replacement devices
o Surgical Valve
 Mechanical heart valve
 Tissue heart valve
o Transcatheter Valve
 Transcatheter Aortic Valve Replacement (TAVR)
 Transcatheter Mitral Valve Replacement (TMVR)
 Transcatheter Pulmonary Valve Replacement (TPVR)
 Others (BAT & CCM)

2) Heart Failure Devices Global Market, Based on Surgery:
 Open Surgery
 Minimally Invasive Surgery
 Robotic Surgery

3) Heart Failure Devices Global Market, Based on End-User:
 Hospitals
 Ambulatory Surgical Centers (ASCs)
 Others (Academics & Research Institutes and OBL)

4) Heart Failure Devices Global Market, Based on Geography:
 North America (U.S. and Rest of N.A.)
 Europe (Germany, France, Italy and the Rest of Europe)
 Asia-Pacific (China, Japan, India and Rest of APAC)
 Rest of the World (Brazil, the Rest of LATAM, the Middle East and Africa)

Each segment of this report offers market values for its sub-segments and geographies as well. It also provides market dynamics with respect to drivers, restraints, opportunities, and the performance of major key players.

As estimated by IQ4I Research, the heart failure devices global market is expected to grow at high single digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities. Adverse events and complications with the implantation of heart failure devices, the high cost of the devices, and the lack of trained professionals are the restraints, whereas, stringent regulatory guidelines and the availability of alternative products are the threats.
The report covers business intelligence information of the heart failure devices market segments based on product, end-users, surgery and geography. Revenue forecast of the heart failure devices market and strategic analysis of each sub-segment with respect to segmental growth trends. Market penetration analysis of structural heart devices, analysis of structural heart devices global market by the number of units and their average selling prices, product approval analysis, funding analysis, global and individual market share analysis of ventricular assist devices (VAD), intra-aortic balloon pump (IABP) devices, ICD devices (Single chamber, dual chamber), Pacemakers (Single chamber, dual chamber), CRTs, annuloplasty devices, occluders and mechanical replacement valves, currently available and pipeline of products with respect to TAVR, TMVR, TPVR and TTVR, profiles of major players in the heart failure devices market and analysis of their product offerings, financial revenue, business strategies and SWOTs.
Some of the major companies in heart failure devices are Abbott Laboratories (U.S.), Abiomed (U.S.), Biotronik (Germany), Boston Scientific Corporation (U.S.), Corcym (U.K.), Edwards Lifesciences Corporation (U.S.), Getinge (Sweden) Medtronic PLC (Ireland), MicroPort Scientific Corporation (China) and Teleflex (U.S.).